Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-02-02
1998-11-24
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435244, 930120, 530323, 530324, C12P 2102
Patent
active
058406875
ABSTRACT:
The invention provides for synthetic ligands that bind to class I receptor tyrosine kinases. The ligands are analogous in structure to naturally occurring ligands. The modified ligands however, have eliminated the mid-sequence (B) domain present in the native ligands and replaced it with a peptide bridge which links the amino (A) and carboxy (C) domains.
REFERENCES:
patent: 5589356 (1996-12-01), Tam
Bahr et al., "Antigenic properties of the second loop of transforming growth factor-.alpha. by synthetic peptides", Acta Chemical Scandinavica (1992) 46:266-270.
Tam et al. "Efficient approach to synthesis of two-chain asynetric cysteine analogs of receptor-binding region of transforming growth factor-.alpha.", Int. J. of Peptide and Protein Res. (1992) 39:464-47.
Brown et al., "Polypeptide" (May 9, 1986), Chem Abs #4 Plus Abs #1987: 114294.
Carpenter, G. "Receptors for Epidermal Growth Factor and Other Polypeptide Mitogens," Ann. Rev. Biochem, (1987) 56:881-914.
Kimball, E. et al. "Epidermal Growth Factor (EGF) Binding to Membranes Immoblized in Microtiter Wells and Estimation of EGF-Related Transforming Growth Factor Activity", Biochimica et Biophysica Acta, (1984) 771:82-88.
DeLarco, J. et al. "Growth factors from murine sarcoma virus-transformed cells", Proc. Natl. Acad. Sci. USA, (1978) 75(8):4001-4005.
Hung, M-C, "The neu Proto-oncogene and Breast Cancer", The Cancer Bulletin, (1988) 40(5):300-303.
Cohen, S. et al. "Human Epidermal Growth Factor: Isolation and Chemical and Biological Properties", Proc. Nat. Acad. Sci. USA, (1975) 72(4):1317-1321.
Winkler, M. et al., "The Purification of Fully Active Recombinant Transforming Growth Factor a Produced in Escherichia coli", The Journal of Biological Chemistry, (1986) 261 (29):13838-13843.
Marquardt, H. et al., "Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: Amino acid sequence homology with epidermal growth factor", Proc. Natl. Acad. Sci. USA, (1983) 80:4684-4688.
Janssen, J. et al., "A novel putative tyrosine kinase receptor with oncogenic potential", Oncogene, (1991) 6:2113-2120.
Zhang, X. et al., "Amplification and rearrangement of c-erb proto-oncogenes in cancer of human female genital tract", Oncogene, (1989) 4:985-989.
O'Bryan, J. et al., "axl , a Transforming Gene Isolated from Primary Human Myeloid Leukemia Cells, Encodes a Novel Receptor Tyrosine Kinase", Molecular and Cellular Biology, (1991) 11(10):5016-5031.
Slamon, D. et al., "Studies of the HER-2/ neu Proto-oncogene in Human Breast and Ovarian Cancer", Science, (1989) 244:707-712.
Slamon, D. et al., "Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene", Science, (1987)235:177-182.
Martin-Zanca, D., et al., "A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences", Nature, (1986) 319:743-748.
Wilks, A., "Protein Tyrosine Kinase Growth Factor Receptors and Their Ligands in Development, Differentiation, and Cancer", Advances in Cancer Research, (1993) 60:43-73.
Spear, K. et al., "Chemical Synthesis of Human Transforming Growth Factor-.alpha.", Techniques in Protein Chemistry II, (1991) 233-240.
Ullrich, A. et al., "Signal Transduction by Receptors with Tyrosine Kinase Activity"; Cell, (1990) 61:203-212.
Harkins Richard N.
Katz Bradley A.
Seto Marian
Delaney Patrick R.
Schering Aktiengesellschaft
Tsang Cecilia J.
Washtien Wendy L.
LandOfFree
Modified ligands for receptor tyrosine kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified ligands for receptor tyrosine kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified ligands for receptor tyrosine kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702183